Detalhe da pesquisa
1.
Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years.
J Allergy Clin Immunol Pract
; 9(12): 4381-4392.e4, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34487870